A review of the psychomotor effects of paroxetine
- PMID: 9179629
- DOI: 10.1097/00004850-199701000-00002
A review of the psychomotor effects of paroxetine
Abstract
All 10 placebo-controlled studies of the psychomotor effects of paroxetine are reviewed. The total number of subjects is 195. The majority of studies show little or no effect of paroxetine on psychomotor function. No adverse effects are apparent at the dose of 20 mg/day, although minor impairments can be identified at 40 mg/day. An overview of the data indicates that at the standard therapeutic dose of 20 mg/day, paroxetine has no psychomotor or behavioural toxicity.
Similar articles
-
Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.Expert Rev Neurother. 2006 Jul;6(7):945-56. doi: 10.1586/14737175.6.7.945. Expert Rev Neurother. 2006. PMID: 16831110 Review.
-
Low doses of controlled-release paroxetine in the treatment of late-life depression: a randomized, placebo-controlled trial.J Clin Psychiatry. 2009 Jan;70(1):46-57. doi: 10.4088/jcp.06m02996. Epub 2008 Oct 7. J Clin Psychiatry. 2009. PMID: 19026248 Clinical Trial.
-
Withdrawal hypomania associated with paroxetine.J Clin Psychopharmacol. 1997 Feb;17(1):60-1. doi: 10.1097/00004714-199702000-00016. J Clin Psychopharmacol. 1997. PMID: 9004064 No abstract available.
-
Serotonin syndrome after a massive overdose of controlled-release paroxetine.Psychosomatics. 2010 Sep-Oct;51(5):437-42. doi: 10.1176/appi.psy.51.5.437. Psychosomatics. 2010. PMID: 20833944
-
Efficacy and tolerability of controlled-release paroxetine.Psychopharmacol Bull. 2003 Spring;37 Suppl 1:176-86. Psychopharmacol Bull. 2003. PMID: 14566210 Review.
Cited by
-
Paroxetine controlled release.CNS Drugs. 2004;18(6):355-64; discussion 365-6. doi: 10.2165/00023210-200418060-00003. CNS Drugs. 2004. PMID: 15089103 Review.
-
Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.CNS Drugs. 1997 Aug;8(2):163-88. doi: 10.2165/00023210-199708020-00010. CNS Drugs. 1997. PMID: 23338224
-
Paroxetine: an update of its use in psychiatric disorders in adults.Drugs. 2002;62(4):655-703. doi: 10.2165/00003495-200262040-00010. Drugs. 2002. PMID: 11893234 Review.
-
Spotlight on paroxetine in psychiatric disorders in adults.CNS Drugs. 2002;16(6):425-34. doi: 10.2165/00023210-200216060-00006. CNS Drugs. 2002. PMID: 12027788 Review.
-
Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.Drugs. 1998 Jan;55(1):85-120. doi: 10.2165/00003495-199855010-00007. Drugs. 1998. PMID: 9463792 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources